These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 28622211)
21. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities. Valicenti-McDermott MR; Demb H J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544 [TBL] [Abstract][Full Text] [Related]
22. Suspected Aripiprazole-induced neutropenia in a geriatric patient: a case report. Torrico T; Kiai N; Meza C; Salam MT; Abdijadid S BMC Geriatr; 2020 May; 20(1):179. PubMed ID: 32448188 [TBL] [Abstract][Full Text] [Related]
23. Aripiprazole and impulse-control disorders in high-risk patients. Mohan T; Dolan S; Mohan R; Dawson J Asian J Psychiatr; 2017 Jun; 27():67-68. PubMed ID: 28558898 [TBL] [Abstract][Full Text] [Related]
24. Development of Hiccup in Male Patients Hospitalized in a Psychiatric Ward: Is it Specifically Related to the Aripiprazole-Benzodiazepine Combination? Caloro M; Pucci D; Calabrò G; de Pisa E; Mancinelli I; Rosini E; Montebovi F; De Filippis S; Telesforo CL; Cuomo I; Kotzalidis GD; Girardi P Clin Neuropharmacol; 2016; 39(2):67-72. PubMed ID: 26818041 [TBL] [Abstract][Full Text] [Related]
26. Incontinence in children with autism spectrum disorder. von Gontard A; Pirrung M; Niemczyk J; Equit M J Pediatr Urol; 2015 Oct; 11(5):264.e1-7. PubMed ID: 26052001 [TBL] [Abstract][Full Text] [Related]
27. Aripiprazole-Induced Hyperlipidemia: An Update. Tarraf C; Naja WJ Prim Care Companion CNS Disord; 2016 Aug; 18(4):. PubMed ID: 27828697 [TBL] [Abstract][Full Text] [Related]
29. [Hypothermia during Treatment with Aripiprazole]. Kozian R; Schmid G; Demian S Psychiatr Prax; 2019 Jan; 46(1):49-51. PubMed ID: 30149396 [TBL] [Abstract][Full Text] [Related]
30. Exacerbation of tics after combining aripiprazole with pimozide: a case with Tourette Syndrome. Mazlum B; Zaimoğlu S; Öztop DB J Clin Psychopharmacol; 2015 Jun; 35(3):350-1. PubMed ID: 25928702 [No Abstract] [Full Text] [Related]
31. Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia. Mullins CD; Obeidat NA; Cuffel BJ; Naradzay J; Loebel AD Schizophr Res; 2008 Jan; 98(1-3):8-15. PubMed ID: 17596914 [TBL] [Abstract][Full Text] [Related]
33. Aripiprazole and Impulse-Control Disorders: A Recent FDA Warning and a Case Report. Dhillon R; Bastiampillai T; Cao CZ; Eckert TG; Tibrewal P Prim Care Companion CNS Disord; 2017 Jan; 19(1):. PubMed ID: 28102975 [No Abstract] [Full Text] [Related]
35. Aripiprazole as a treatment option for clozapine-induced enuresis. Palaniappan P Indian J Pharmacol; 2015; 47(5):574-5. PubMed ID: 26600658 [No Abstract] [Full Text] [Related]
36. Metabolic syndrome and drug discontinuation in schizophrenia: a randomized trial comparing aripiprazole olanzapine and haloperidol. Parabiaghi A; Tettamanti M; D'Avanzo B; Barbato A; Acta Psychiatr Scand; 2016 Jan; 133(1):63-75. PubMed ID: 26252780 [TBL] [Abstract][Full Text] [Related]
37. Risk of Extrapyramidal Adverse Events With Aripiprazole. Etminan M; Procyshyn RM; Samii A; Carleton BC J Clin Psychopharmacol; 2016 Oct; 36(5):472-4. PubMed ID: 27580493 [TBL] [Abstract][Full Text] [Related]
38. Covert Dyskinesia With Aripiprazole: A Case Report. Mahgoub Y; Hameed A; Francis A Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27722028 [No Abstract] [Full Text] [Related]